A citation-based method for searching scientific literature

Emanuele Giurisato, Qiuping Xu, Silvia Lonardi, Brian Telfer, Ilaria Russo, Adam Pearson, Katherine G Finegan, Wenbin Wang, Jinhua Wang, Nathanael S Gray, William Vermi, Zhengui Xia, Cathy Tournier. Proc Natl Acad Sci U S A 2018
Times Cited: 49







List of co-cited articles
660 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


ERK5 is activated by oncogenic BRAF and promotes melanoma growth.
Ignazia Tusa, Sinforosa Gagliardi, Alessandro Tubita, Silvia Pandolfi, Carmelo Urso, Lorenzo Borgognoni, Jinhua Wang, Xianming Deng, Nathanael S Gray, Barbara Stecca,[...]. Oncogene 2018
34
29

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
20

Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity.
Marcin Kortylewski, Maciej Kujawski, Tianhong Wang, Sheng Wei, Shumin Zhang, Shari Pilon-Thomas, Guilian Niu, Heidi Kay, James Mulé, William G Kerr,[...]. Nat Med 2005
729
20

ERK5: structure, regulation and function.
Gopika N Nithianandarajah-Jones, Bettina Wilm, Christopher E P Goldring, Jürgen Müller, Michael J Cross. Cell Signal 2012
141
18

Tumor-associated macrophages: from mechanisms to therapy.
Roy Noy, Jeffrey W Pollard. Immunity 2014
18

Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein.
Qingkai Yang, Xianming Deng, Bingwen Lu, Michael Cameron, Colleen Fearns, Matthew P Patricelli, John R Yates, Nathanael S Gray, Jiing-Dwan Lee. Cancer Cell 2010
145
18

The MEK5/ERK5 signalling pathway in cancer: a promising novel therapeutic target.
André E S Simões, Cecília M P Rodrigues, Pedro M Borralho. Drug Discov Today 2016
49
16

ERK5 kinase activity is dispensable for cellular immune response and proliferation.
Emme C K Lin, Christopher M Amantea, Tyzoon K Nomanbhoy, Helge Weissig, Junichi Ishiyama, Yi Hu, Shyama Sidique, Bei Li, John W Kozarich, Jonathan S Rosenblum. Proc Natl Acad Sci U S A 2016
49
16

ERK5 is a critical mediator of inflammation-driven cancer.
Katherine G Finegan, Diana Perez-Madrigal, James R Hitchin, Clare C Davies, Allan M Jordan, Cathy Tournier. Cancer Res 2015
41
19

The cellular and molecular origin of tumor-associated macrophages.
Ruth A Franklin, Will Liao, Abira Sarkar, Myoungjoo V Kim, Michael R Bivona, Kang Liu, Eric G Pamer, Ming O Li. Science 2014
774
16

Erk5 Is a Key Regulator of Naive-Primed Transition and Embryonic Stem Cell Identity.
Charles A C Williams, Rosalia Fernandez-Alonso, Jinhua Wang, Rachel Toth, Nathanael S Gray, Greg M Findlay. Cell Rep 2016
28
25


STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients.
David Vasquez-Dunddel, Fan Pan, Qi Zeng, Mikhail Gorbounov, Emilia Albesiano, Juan Fu, Richard L Blosser, Ada J Tam, Tullia Bruno, Hao Zhang,[...]. J Clin Invest 2013
346
14

Revisiting STAT3 signalling in cancer: new and unexpected biological functions.
Hua Yu, Heehyoung Lee, Andreas Herrmann, Ralf Buettner, Richard Jove. Nat Rev Cancer 2014
14

Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment.
Marcin Kortylewski, Hong Xin, Maciej Kujawski, Heehyoung Lee, Yong Liu, Timothy Harris, Charles Drake, Drew Pardoll, Hua Yu. Cancer Cell 2009
340
14

XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism.
Sripathi M Sureban, Randal May, Nathaniel Weygant, Dongfeng Qu, Parthasarathy Chandrakesan, Eddie Bannerman-Menson, Naushad Ali, Panayotis Pantazis, Christoph B Westphalen, Timothy C Wang,[...]. Cancer Lett 2014
87
14


Multisite phosphorylation of Erk5 in mitosis.
Elena Díaz-Rodríguez, Atanasio Pandiella. J Cell Sci 2010
37
18

Activation of a C-terminal transcriptional activation domain of ERK5 by autophosphorylation.
Hiroko Morimoto, Kunio Kondoh, Satoko Nishimoto, Kazuya Terasawa, Eisuke Nishida. J Biol Chem 2007
76
14

Phosphorylation of ERK5 on Thr732 is associated with ERK5 nuclear localization and ERK5-dependent transcription.
Takuto Honda, Yutaro Obara, Arata Yamauchi, Anthony D Couvillon, Justin J Mason, Kuniaki Ishii, Norimichi Nakahata. PLoS One 2015
23
30

MEK5/ERK5 activation regulates colon cancer stem-like cell properties.
Diane M Pereira, Sofia E Gomes, Pedro M Borralho, Cecília M P Rodrigues. Cell Death Discov 2019
28
25

Tumour-associated macrophages as treatment targets in oncology.
Alberto Mantovani, Federica Marchesi, Alberto Malesci, Luigi Laghi, Paola Allavena. Nat Rev Clin Oncol 2017
14

Multifunctional role of Erk5 in multiple myeloma.
Xonia Carvajal-Vergara, Soraya Tabera, Juan C Montero, Azucena Esparís-Ogando, Ricardo López-Pérez, Gema Mateo, Norma Gutiérrez, Marisa Parmo-Cabañas, Joaquín Teixidó, Jesús F San Miguel,[...]. Blood 2005
72
12


Macrophage plasticity and polarization: in vivo veritas.
Antonio Sica, Alberto Mantovani. J Clin Invest 2012
12

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.
Hua Yu, Marcin Kortylewski, Drew Pardoll. Nat Rev Immunol 2007
12

MAPK7 Regulates EMT Features and Modulates the Generation of CTCs.
Sarah Javaid, Jianmin Zhang, Gromoslaw A Smolen, Min Yu, Ben S Wittner, Anurag Singh, Kshitij S Arora, Marissa W Madden, Rushil Desai, Matthew J Zubrowski,[...]. Mol Cancer Res 2015
35
17

Aberrant MEK5/ERK5 signalling contributes to human colon cancer progression via NF-κB activation.
A E S Simões, D M Pereira, S E Gomes, H Brito, T Carvalho, A French, R E Castro, C J Steer, S N Thibodeau, C M P Rodrigues,[...]. Cell Death Dis 2015
35
17

MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion.
P B Mehta, B L Jenkins, L McCarthy, L Thilak, C N Robson, D E Neal, H Y Leung. Oncogene 2003
141
12

ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation.
Petrus R de Jong, Koji Taniguchi, Alexandra R Harris, Samuel Bertin, Naoki Takahashi, Jen Duong, Alejandro D Campos, Garth Powis, Maripat Corr, Michael Karin,[...]. Nat Commun 2016
46
13

Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma.
Chengli Song, Lina Wang, Qiang Xu, Kai Wang, Dan Xie, Zhe Yu, Kui Jiang, Lujian Liao, John R Yates, Jiing-Dwan Lee,[...]. Sci Rep 2017
18
33

ERK5 signalling in prostate cancer promotes an invasive phenotype.
A K Ramsay, S R C McCracken, M Soofi, J Fleming, A X Yu, I Ahmad, R Morland, L Machesky, C Nixon, D R Edwards,[...]. Br J Cancer 2011
67
12

Targeting the Extracellular Signal-Regulated Kinase 5 Pathway to Suppress Human Chronic Myeloid Leukemia Stem Cells.
Ignazia Tusa, Giulia Cheloni, Martina Poteti, Antonella Gozzini, Ngoc Ho DeSouza, Yi Shan, Xianming Deng, Nathanael S Gray, Shaoguang Li, Elisabetta Rovida,[...]. Stem Cell Reports 2018
14
42

The mitogen-activated protein kinase ERK5 regulates the development and growth of hepatocellular carcinoma.
Elisabetta Rovida, Giovanni Di Maira, Ignazia Tusa, Stefania Cannito, Claudia Paternostro, Nadia Navari, Elisa Vivoli, Xianming Deng, Nathanael S Gray, Azucena Esparís-Ogando,[...]. Gut 2015
44
13


Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification are not addicted to ERK5 activity for cell proliferation.
Pamela A Lochhead, Jonathan Clark, Lan-Zhen Wang, Lesley Gilmour, Matthew Squires, Rebecca Gilley, Caroline Foxton, David R Newell, Stephen R Wedge, Simon J Cook. Cell Cycle 2016
23
26


Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.
Alberto Mantovani, Silvano Sozzani, Massimo Locati, Paola Allavena, Antonio Sica. Trends Immunol 2002
12

Distinct role of macrophages in different tumor microenvironments.
Claire E Lewis, Jeffrey W Pollard. Cancer Res 2006
12



ERK5 activates NF-kappaB in leukemic T cells and is essential for their growth in vivo.
Johan Garaude, Seyma Cherni, Sandra Kaminski, Etienne Delepine, Christine Chable-Bessia, Monsef Benkirane, Joana Borges, Atanasio Pandiella, Miguel Angel Iñiguez, Manuel Fresno,[...]. J Immunol 2006
56
10

miR-143 interferes with ERK5 signaling, and abrogates prostate cancer progression in mice.
Cyrielle Clapé, Vanessa Fritz, Corinne Henriquet, Florence Apparailly, Pedro Luis Fernandez, François Iborra, Christophe Avancès, Martin Villalba, Stéphane Culine, Lluis Fajas. PLoS One 2009
155
10

Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors.
Vinit Kumar, Laxminarasimha Donthireddy, Douglas Marvel, Thomas Condamine, Fang Wang, Sergio Lavilla-Alonso, Ayumi Hashimoto, Prashanthi Vonteddu, Reeti Behera, Marlee A Goins,[...]. Cancer Cell 2017
305
10

AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer.
David Hong, Razelle Kurzrock, Youngsoo Kim, Richard Woessner, Anas Younes, John Nemunaitis, Nathan Fowler, Tianyuan Zhou, Joanna Schmidt, Minji Jo,[...]. Sci Transl Med 2015
249
10

STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis.
Chanyu Yue, Shudan Shen, Jiehui Deng, Saul J Priceman, Wenzhao Li, Austin Huang, Hua Yu. Cancer Immunol Res 2015
55
10

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells.
Tianhong Wang, Guilian Niu, Marcin Kortylewski, Lyudmila Burdelya, Kenneth Shain, Shumin Zhang, Raka Bhattacharya, Dmitry Gabrilovich, Richard Heller, Domenico Coppola,[...]. Nat Med 2004
826
10

A critical role for Stat3 signaling in immune tolerance.
Fengdong Cheng, Hong-Wei Wang, Alex Cuenca, Mei Huang, Tomar Ghansah, Jason Brayer, William G Kerr, Kiyoshi Takeda, Shizuo Akira, Stephen P Schoenberger,[...]. Immunity 2003
286
10

STATs in cancer inflammation and immunity: a leading role for STAT3.
Hua Yu, Drew Pardoll, Richard Jove. Nat Rev Cancer 2009
10

Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells.
Andreas Herrmann, Marcin Kortylewski, Maciej Kujawski, Chunyan Zhang, Karen Reckamp, Brian Armstrong, Lin Wang, Claudia Kowolik, Jiehui Deng, Robert Figlin,[...]. Cancer Res 2010
91
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.